Impact of waning immunity against SARS-CoV-2 severity exacerbated by vaccine hesitancy
Fig 5
Synoptic landscapes with vaccine heterogeneities, caused by either unequal access or hesitancy.
We assume a 2% weekly vaccination rate (c.f.bottom row, Fig 4), and keep the average vaccination rate constant across each row so that the vaccination rate among vaccine-adopters is ν, where νN1 = 0.02 (N1 = 1 − N2 is the fraction of vaccine adopters, and N2 is the fraction of individuals that are vaccine-hesitant). The columnar scenarios are as in those of Fig 4.